CN Stock MarketDetailed Quotes

600750 Jiangzhong Pharmaceutical

Watchlist
  • 26.48
  • -0.10-0.38%
Not Open May 28 15:00 CST
16.66BMarket Cap22.75P/E (TTM)

Jiangzhong Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-8.74%1.23B
13.00%4.39B
9.24%3.14B
20.87%2.3B
44.50%1.34B
35.19%3.89B
48.33%2.87B
50.12%1.9B
37.38%930.73M
17.72%2.87B
Operating revenue
-8.74%1.23B
13.00%4.39B
9.24%3.14B
20.87%2.3B
44.50%1.34B
35.19%3.89B
48.33%2.87B
50.12%1.9B
37.38%930.73M
17.72%2.87B
Other operating revenue
----
-33.80%26.21M
----
-48.82%21.95M
----
121.34%39.58M
----
1,408.43%42.89M
----
159.20%17.88M
Total operating cost
-15.24%899.42M
8.30%3.5B
6.44%2.46B
22.22%1.78B
47.03%1.06B
38.08%3.23B
59.61%2.31B
56.42%1.46B
42.84%721.7M
23.38%2.34B
Operating cost
-13.08%383.29M
10.02%1.52B
5.48%1.01B
15.82%735.41M
49.36%440.96M
35.07%1.38B
46.96%961.56M
48.85%634.98M
25.82%295.23M
21.21%1.02B
Operating tax surcharges
1.58%17.71M
4.84%62.65M
0.45%45.99M
-0.53%31.65M
15.32%17.43M
13.93%59.75M
15.66%45.78M
21.50%31.82M
12.69%15.12M
14.74%52.45M
Operating expense
-16.14%451.23M
7.99%1.63B
9.03%1.23B
32.68%905.36M
52.34%538.07M
46.17%1.51B
78.13%1.12B
71.78%682.39M
60.73%353.21M
26.42%1.03B
Administration expense
-20.98%39.86M
2.34%210.62M
13.92%143.91M
16.60%92.2M
32.51%50.45M
24.70%205.8M
30.95%126.33M
19.66%79.08M
54.28%38.07M
12.78%165.03M
Financial expense
-71.23%-21.29M
-116.74%-59.8M
-96.80%-43.28M
-107.66%-26.5M
-57.37%-12.43M
-23.07%-27.59M
3.43%-21.99M
19.36%-12.76M
-19.83%-7.9M
-71.61%-22.42M
-Interest expense (Financial expense)
-98.96%16.8K
59.38%6.98M
140.90%3.87M
149.32%3.42M
2,824.40%1.62M
26.51%4.38M
10,874.70%1.61M
8,188.57%1.37M
--55.46K
79.55%3.46M
-Interest Income (Financial expense)
-51.29%-21.41M
-107.29%-67.64M
-98.42%-47.84M
-110.13%-30.11M
-75.83%-14.15M
-24.08%-32.63M
-4.94%-24.11M
10.34%-14.33M
-20.51%-8.05M
-72.26%-26.3M
Research and development
7.41%28.62M
33.37%133.33M
-2.80%70.84M
3.88%45.75M
-4.76%26.64M
13.83%99.97M
52.60%72.88M
34.29%44.04M
44.51%27.97M
58.09%87.82M
Credit Impairment Loss
658.32%11.4M
92.70%-1.03M
8.86%7.13M
15.03%5.02M
-56.14%1.5M
-74.70%-14.05M
616.53%6.55M
648.54%4.37M
383.23%3.43M
-512.32%-8.04M
Asset Impairment Loss
---8.22M
-7,770.23%-8.85M
-99.80%4.95K
-99.88%4.95K
----
91.85%-112.5K
2,002.27%2.54M
4,248.57%4.28M
10,240.57%3.73M
40.04%-1.38M
Other net revenue
-60.14%7.23M
-97.88%1.98M
-41.68%43.64M
-16.51%42.87M
-10.58%18.14M
2.08%93.11M
13.93%74.82M
36.98%51.35M
16.29%20.29M
220.70%91.21M
Fair value change income
-91.35%620.29K
-164.99%-37.11M
-85.18%5.7M
-23.04%17.21M
-22.10%7.17M
6.50%57.1M
25.15%38.49M
29.49%22.36M
-10.35%9.2M
602.90%53.61M
Invest income
55.27%-156.92K
-167.23%-2.94M
-81.43%953.69K
-103.82%-158.59K
-129.50%-350.86K
284.88%4.37M
2,688.24%5.14M
561.45%4.15M
1,386.80%1.19M
55.53%-2.36M
-Including: Investment income associates
41.35%-205.78K
-257.74%-2.94M
72.57%953.69K
-134.83%-158.59K
-129.23%-350.86K
72.82%-821.16K
216.85%552.65K
148.86%455.35K
874.77%1.2M
65.08%-3.02M
Asset deal income
7,296.53%43.74K
1,008.80%1.22M
-88.47%5.73K
-90.02%5.24K
117.77%591.41
-114.87%-134.14K
-94.50%49.7K
-94.20%52.5K
-100.37%-3.33K
533.02%902.09K
Other revenue
-63.92%3.54M
10.34%50.68M
35.20%29.84M
28.86%20.79M
258.01%9.82M
-5.25%45.93M
-33.22%22.07M
-18.25%16.13M
-64.00%2.74M
0.50%48.48M
Operating profit
11.03%335.22M
19.47%894.12M
13.41%726.61M
12.96%556.54M
31.66%301.91M
19.56%748.41M
14.99%640.71M
32.93%492.68M
20.90%229.31M
9.07%625.99M
Add:Non operating Income
-76.30%1.2M
23.93%9.07M
226.25%7.91M
306.72%5.42M
645.58%5.05M
237.74%7.32M
65.20%2.42M
46.92%1.33M
3.22%677.15K
-73.13%2.17M
Less:Non operating expense
-28.85%356.7K
147.59%6.05M
29.68%1.36M
19.53%902.48K
289.21%501.3K
-51.25%2.44M
-56.43%1.05M
215.18%755.02K
19.77%128.8K
92.90%5.01M
Total profit
9.66%336.06M
19.10%897.13M
14.18%733.16M
13.75%561.05M
33.32%306.46M
20.88%753.28M
15.43%642.08M
32.85%493.25M
20.84%229.86M
7.55%623.14M
Less:Income tax cost
10.25%51.51M
22.06%130.47M
4.62%108.49M
8.12%86.92M
28.83%46.72M
15.94%106.89M
15.44%103.7M
46.01%80.39M
29.06%36.26M
3.50%92.19M
Net profit
9.55%284.55M
18.61%766.66M
16.03%624.67M
14.84%474.14M
34.17%259.74M
21.74%646.39M
15.42%538.38M
30.56%412.86M
19.41%193.6M
8.29%530.95M
Net profit from continuing operation
9.55%284.55M
18.61%766.66M
16.03%624.67M
14.84%474.14M
34.17%259.74M
21.74%646.39M
15.42%538.38M
30.56%412.86M
19.41%193.6M
8.29%530.95M
Less:Minority Profit
3.38%17.77M
21.22%58.37M
5.23%35.19M
31.92%27.13M
73.60%17.18M
90.61%48.15M
128.98%33.44M
112.98%20.57M
257.10%9.9M
52.33%25.26M
Net profit of parent company owners
9.99%266.78M
18.40%708.29M
16.74%589.48M
13.95%447M
32.04%242.56M
18.30%598.24M
11.75%504.94M
27.96%392.29M
15.28%183.7M
6.74%505.69M
Earning per share
Basic earning per share
10.26%0.43
17.89%1.12
16.25%0.93
12.90%0.7
34.48%0.39
18.75%0.95
11.11%0.8
26.53%0.62
16.00%0.29
6.67%0.8
Diluted earning per share
10.26%0.43
17.89%1.12
16.25%0.93
12.90%0.7
34.48%0.39
18.75%0.95
11.11%0.8
26.53%0.62
16.00%0.29
6.67%0.8
Other composite income
Total composite income
9.55%284.55M
18.61%766.66M
16.03%624.67M
14.84%474.14M
34.17%259.74M
21.74%646.39M
15.42%538.38M
30.56%412.86M
19.41%193.6M
8.29%530.95M
Total composite income of parent company owners
9.99%266.78M
18.40%708.29M
16.74%589.48M
13.95%447M
32.04%242.56M
18.30%598.24M
11.75%504.94M
27.96%392.29M
15.28%183.7M
6.74%505.69M
Total composite income of minority owners
3.38%17.77M
21.22%58.37M
5.23%35.19M
31.92%27.13M
73.60%17.18M
90.61%48.15M
128.98%33.44M
112.98%20.57M
257.10%9.9M
52.33%25.26M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -8.74%1.23B13.00%4.39B9.24%3.14B20.87%2.3B44.50%1.34B35.19%3.89B48.33%2.87B50.12%1.9B37.38%930.73M17.72%2.87B
Operating revenue -8.74%1.23B13.00%4.39B9.24%3.14B20.87%2.3B44.50%1.34B35.19%3.89B48.33%2.87B50.12%1.9B37.38%930.73M17.72%2.87B
Other operating revenue -----33.80%26.21M-----48.82%21.95M----121.34%39.58M----1,408.43%42.89M----159.20%17.88M
Total operating cost -15.24%899.42M8.30%3.5B6.44%2.46B22.22%1.78B47.03%1.06B38.08%3.23B59.61%2.31B56.42%1.46B42.84%721.7M23.38%2.34B
Operating cost -13.08%383.29M10.02%1.52B5.48%1.01B15.82%735.41M49.36%440.96M35.07%1.38B46.96%961.56M48.85%634.98M25.82%295.23M21.21%1.02B
Operating tax surcharges 1.58%17.71M4.84%62.65M0.45%45.99M-0.53%31.65M15.32%17.43M13.93%59.75M15.66%45.78M21.50%31.82M12.69%15.12M14.74%52.45M
Operating expense -16.14%451.23M7.99%1.63B9.03%1.23B32.68%905.36M52.34%538.07M46.17%1.51B78.13%1.12B71.78%682.39M60.73%353.21M26.42%1.03B
Administration expense -20.98%39.86M2.34%210.62M13.92%143.91M16.60%92.2M32.51%50.45M24.70%205.8M30.95%126.33M19.66%79.08M54.28%38.07M12.78%165.03M
Financial expense -71.23%-21.29M-116.74%-59.8M-96.80%-43.28M-107.66%-26.5M-57.37%-12.43M-23.07%-27.59M3.43%-21.99M19.36%-12.76M-19.83%-7.9M-71.61%-22.42M
-Interest expense (Financial expense) -98.96%16.8K59.38%6.98M140.90%3.87M149.32%3.42M2,824.40%1.62M26.51%4.38M10,874.70%1.61M8,188.57%1.37M--55.46K79.55%3.46M
-Interest Income (Financial expense) -51.29%-21.41M-107.29%-67.64M-98.42%-47.84M-110.13%-30.11M-75.83%-14.15M-24.08%-32.63M-4.94%-24.11M10.34%-14.33M-20.51%-8.05M-72.26%-26.3M
Research and development 7.41%28.62M33.37%133.33M-2.80%70.84M3.88%45.75M-4.76%26.64M13.83%99.97M52.60%72.88M34.29%44.04M44.51%27.97M58.09%87.82M
Credit Impairment Loss 658.32%11.4M92.70%-1.03M8.86%7.13M15.03%5.02M-56.14%1.5M-74.70%-14.05M616.53%6.55M648.54%4.37M383.23%3.43M-512.32%-8.04M
Asset Impairment Loss ---8.22M-7,770.23%-8.85M-99.80%4.95K-99.88%4.95K----91.85%-112.5K2,002.27%2.54M4,248.57%4.28M10,240.57%3.73M40.04%-1.38M
Other net revenue -60.14%7.23M-97.88%1.98M-41.68%43.64M-16.51%42.87M-10.58%18.14M2.08%93.11M13.93%74.82M36.98%51.35M16.29%20.29M220.70%91.21M
Fair value change income -91.35%620.29K-164.99%-37.11M-85.18%5.7M-23.04%17.21M-22.10%7.17M6.50%57.1M25.15%38.49M29.49%22.36M-10.35%9.2M602.90%53.61M
Invest income 55.27%-156.92K-167.23%-2.94M-81.43%953.69K-103.82%-158.59K-129.50%-350.86K284.88%4.37M2,688.24%5.14M561.45%4.15M1,386.80%1.19M55.53%-2.36M
-Including: Investment income associates 41.35%-205.78K-257.74%-2.94M72.57%953.69K-134.83%-158.59K-129.23%-350.86K72.82%-821.16K216.85%552.65K148.86%455.35K874.77%1.2M65.08%-3.02M
Asset deal income 7,296.53%43.74K1,008.80%1.22M-88.47%5.73K-90.02%5.24K117.77%591.41-114.87%-134.14K-94.50%49.7K-94.20%52.5K-100.37%-3.33K533.02%902.09K
Other revenue -63.92%3.54M10.34%50.68M35.20%29.84M28.86%20.79M258.01%9.82M-5.25%45.93M-33.22%22.07M-18.25%16.13M-64.00%2.74M0.50%48.48M
Operating profit 11.03%335.22M19.47%894.12M13.41%726.61M12.96%556.54M31.66%301.91M19.56%748.41M14.99%640.71M32.93%492.68M20.90%229.31M9.07%625.99M
Add:Non operating Income -76.30%1.2M23.93%9.07M226.25%7.91M306.72%5.42M645.58%5.05M237.74%7.32M65.20%2.42M46.92%1.33M3.22%677.15K-73.13%2.17M
Less:Non operating expense -28.85%356.7K147.59%6.05M29.68%1.36M19.53%902.48K289.21%501.3K-51.25%2.44M-56.43%1.05M215.18%755.02K19.77%128.8K92.90%5.01M
Total profit 9.66%336.06M19.10%897.13M14.18%733.16M13.75%561.05M33.32%306.46M20.88%753.28M15.43%642.08M32.85%493.25M20.84%229.86M7.55%623.14M
Less:Income tax cost 10.25%51.51M22.06%130.47M4.62%108.49M8.12%86.92M28.83%46.72M15.94%106.89M15.44%103.7M46.01%80.39M29.06%36.26M3.50%92.19M
Net profit 9.55%284.55M18.61%766.66M16.03%624.67M14.84%474.14M34.17%259.74M21.74%646.39M15.42%538.38M30.56%412.86M19.41%193.6M8.29%530.95M
Net profit from continuing operation 9.55%284.55M18.61%766.66M16.03%624.67M14.84%474.14M34.17%259.74M21.74%646.39M15.42%538.38M30.56%412.86M19.41%193.6M8.29%530.95M
Less:Minority Profit 3.38%17.77M21.22%58.37M5.23%35.19M31.92%27.13M73.60%17.18M90.61%48.15M128.98%33.44M112.98%20.57M257.10%9.9M52.33%25.26M
Net profit of parent company owners 9.99%266.78M18.40%708.29M16.74%589.48M13.95%447M32.04%242.56M18.30%598.24M11.75%504.94M27.96%392.29M15.28%183.7M6.74%505.69M
Earning per share
Basic earning per share 10.26%0.4317.89%1.1216.25%0.9312.90%0.734.48%0.3918.75%0.9511.11%0.826.53%0.6216.00%0.296.67%0.8
Diluted earning per share 10.26%0.4317.89%1.1216.25%0.9312.90%0.734.48%0.3918.75%0.9511.11%0.826.53%0.6216.00%0.296.67%0.8
Other composite income
Total composite income 9.55%284.55M18.61%766.66M16.03%624.67M14.84%474.14M34.17%259.74M21.74%646.39M15.42%538.38M30.56%412.86M19.41%193.6M8.29%530.95M
Total composite income of parent company owners 9.99%266.78M18.40%708.29M16.74%589.48M13.95%447M32.04%242.56M18.30%598.24M11.75%504.94M27.96%392.29M15.28%183.7M6.74%505.69M
Total composite income of minority owners 3.38%17.77M21.22%58.37M5.23%35.19M31.92%27.13M73.60%17.18M90.61%48.15M128.98%33.44M112.98%20.57M257.10%9.9M52.33%25.26M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg